|Project Title||Multiple Sclerosis Relapses among Copaxone, Glatopa, Gilenya, and Glatiramer Users|
The goals of this request were to 1) estimate the rate of multiple sclerosis (MS) relapses among Copaxone, Glatopa, Gilenya, and glatiramer users and 2) compare MS relapse algorithms in the Sentinel Distributed Database (SDD). Data from September 21, 2010 to January 31, 2018 from 17 Data Partners contributing to the SDD were included in this report.
Tuesday, September 17, 2019
Modular Programs and Summary Tables
- Vaccines, Blood & Biologics
- Devices and Radiologic Health